Justice ministry confirms legal aid requests in Greece-Novartis scandal
Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States linked to probes into Novartis and alleged bribes involving the Swiss drugmaker and Greek doctors and public officials.
This content was published on
2 minutes
SDA-ATS/RTS/sb
The two requests for legal assistance linked to the Novartis-Greek scandal were received at the end of last year and in January 2018 and are being studied, a justice ministry official confirmed to Swiss public television, RTS, and the Swiss News Agency on Saturday.
The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based NovartisExternal link over nearly a decade to boost subscriptions of their products at public hospitals. The ten prominent politicians linked to the bribery scandal include two former Greek prime ministers and eight former ministers. They are alleged to have been involved in approving Novartis contracts and overcharging in return for kickbacks. All deny the allegations.
Greece’s Justice Minister Stavros Kontonis last year said Novartis had likely bribed “thousands” of doctors and civil servants to promote its products. He also accused Novartis of continuing to sell “overpriced” drugs even after the country was plunged into economic crisis in 2010 and huge cuts were imposed on state budgets, leaving many Greeks without access to affordable medicine.
Novartis overcharges alone are estimated to have cost the Greek state some €3 billion euros ($3.7 billion). Overall, similar practises across the health sector cost Greece some €23 billion between 2000 and 2015, investigators have said.
The Greek branch of Novartis has issued a statement saying it was “aware of the media reports about our business practices” in Greece and that it was cooperating with the authorities, the Swiss News Agency said.
More
More
Greece investigates Novartis for alleged bribery
This content was published on
Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.
Switzerland abstains from vote on Palestinian bid for full UN membership
This content was published on
On Friday, Switzerland abstained from the vote at the General Assembly on granting the Palestinians new rights at the United Nations (UN).
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
This content was published on
Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.
This content was published on
Vas Narasimhan estimates that using digital technology more efficiently could save up to 25% on the cost of clinical trials.
This content was published on
The employees are believed to have offered illegal rebates and kickbacks to doctors amounting to 2.6 billion won (CHF 2.3 million) between 2011 and 2016. Altogether, 34 people – including 15 doctors and five heads of medical journals – have been included in the investigation, which began in February when authorities raided the Novartis Korea…
Will exclusive collaborations yield more drug breakthroughs?
This content was published on
Recently FDA-approved, Novartis's pioneering immunotherapy was developed through an agreement with University of Pennsylvania researchers.
This content was published on
Swiss pharmaceutical giant Novartis has dismissed claims from an internal whistleblower that it bribed Turkish officials.
Pharma turns to big data to gauge care and pricing
This content was published on
Struggling to keep pace with digitisation, big pharma companies are turning to big data to drive future growth. Swiss-based Novartis is no different.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.